Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002462-24Phase 3Completed
Phase 3, open-label trial of levothyroxine sodium in congenital hypothyroidism (CH) (2 arms), sponsored by Universal Pharmaceutical Industries UNIPHARMA. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002462-24.